Le Lézard
Classified in: Health, Science and technology
Subject: FDA

ACell Announces Additional Clearances for Gentrix Surgical Matrix Family of Products


COLUMBIA, Md., April 3, 2019 /PRNewswire/ -- ACell, Inc. today announced that it has received a new 510(k) clearance from the US Food and Drug Administration (FDA) covering several devices in its Gentrix® Surgical Matrix suite of products.

ACell, Inc. Logo (PRNewsfoto/ACell, Inc.)

The clearance updates the indications for use for Gentrix Surgical Matrix, Gentrix Surgical Matrix Thin, and Gentrix Surgical Matrix Plus, adding important new claims to the product labeling.  Notably, these devices were shown to minimize unwanted attachment to surrounding visceral tissue.  Further, ACell gained the specific indication for use of these three Gentrix devices in laparoscopic applications.  Finally, ACell obtained clearance for a new hernia device configuration specifically indicated for reinforcement of hiatal hernia repairs. 

"ACell continues to expand its presence in the hernia marketplace," said Patrick McBrayer, President and CEO. "This milestone from the FDA is another strategic building block in our objective to meet the needs of clinicians and patients with safe, cost-efficient, and clinically effective devices for complex hernia repair."

"These clearances are especially impactful in supporting the use of Gentrix Surgical Matrix devices in minimally invasive hernia repairs.  Surgeons performing such repairs know that if they heal with the formation of excess scar tissue, they are at risk for devastating complications, potential re-operations, and increased healthcare costs," said Hazem Elariny, MD, Medical Director.  "Additionally, if a surgeon chooses to utilize a product in the intraperitoneal fashion, the demonstrated minimal attachment to surrounding tissue makes Gentrix an ideal option in these cases."

The pre-clinical data used to support the new clearances will be presented in two posters at the Society of American Gastrointestinal and Endoscopic Surgeons Annual Meeting in Baltimore, Maryland April 3-6.  The first poster describes data that shows the minimization of tissue attachments to Gentrix when in contact with viscera. The study assessed the ability of two surgical grafts ? Gentrix and SIS (small intestinal submucosa) ? to minimize tissue attachments to the device in a rabbit model of intraperitoneal device placement, and concluded that the Gentrix devices performed similar or better than the SIS grafts. A second poster will also be presented to describe the performance of Gentrix in a preclinical model of laparoscopic hiatal hernia repair.

About ACell, Inc.
ACell, Inc. is a leading regenerative medicine company focused on the development, manufacturing, and commercialization of medical devices for surgical soft tissue repair and wound management.  ACell is committed to becoming and remaining an innovative leader in regenerative medical technology, offering superior healing options for doctors and patients.  ACell is a privately held company and operates manufacturing facilities in Columbia, MD and Lafayette, IN. 

About Gentrix Surgical Matrix
Gentrix® Surgical Matrix Thin (3-layer) is intended for implantation to reinforce soft tissue where weakness exists in patients requiring urological, gastroenterological, or plastic & reconstructive surgery. Reinforcement of soft tissue within urological, gastroenterological, and plastic & reconstructive surgery includes, but is not limited to, the following open or laparoscopic procedures: hernia and body wall repair, colon and rectal prolapse repair, tissue repair, and esophageal repair. The Gentrix® Surgical Matrix Thin (3-layer) minimizes tissue attachment to the device in case of direct contact with viscera.

Gentrix® Surgical Matrix and Gentrix® Surgical Matrix Plus (6-layer and 8-Layer) are intended for implantation to reinforce soft tissue where weakness exists in patients requiring gastroenterological or plastic & reconstructive surgery. Reinforcement of soft tissue within gastroenterological and plastic & reconstructive surgery includes, but is not limited to, the following open or laparoscopic procedures: hernia (e.g.: hiatal/diaphragmatic) and body wall repair, colon and rectal prolapse repair, tissue repair, and esophageal repair. The Gentrix® Surgical Matrix and Gentrix® Surgical Matrix Plus (6-layer and 8-Layer) minimizes tissue attachment to the device in case of direct contact with viscera.

SOURCE ACell, Inc.


These press releases may also interest you

at 21:30
"In the complex world of healthcare benefits, members want an easy and quick answer to their most pressing questions. Instead of calling in or searching online, our smart assistant follows this trend and offers the most convenient way to find your...

at 21:26
Potomac Financial Group (PFG), a Maryland-based provider of financial planning and wealth management services, recently announced the launch of Freedom7, a proprietary 7-step financial planning process. Developed to help simplify the financial...

at 21:15
Carvana Co. ("Carvana") , a leading e-commerce platform for buying and selling used cars, today announced that it has priced the private placement of an additional $250.0 million aggregate principal amount of its 8.875% senior...

at 21:00
Spectral Edge, an image processing IP company based in Cambridge UK, has been identified as an innovative start-up by the Talents@Taipei organisation and invited to exhibit at Computex Taipei as part of a global program to foster international...

at 20:59
VanadiumCorp Resource Inc. (the "Company") is pleased to announce the appointment of Mr. Marc Kok to the Board of Directors of VanadiumCorp. "We are pleased to welcome Marc to VanadiumCorp's Board of Directors" stated...

at 20:30
Silicon Valley-based firm announced Founder/CEO Leslie Magsalay-Zeller transforms Pooki's Mahi® manufacturing into a "Digital Beverage Supply Chain" by enforcing a Just-In-Time (JIT) operations model for an FDA certified facility. The technology...



News published on 3 april 2019 at 06:55 and distributed by: